SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BL-M11D1, an antibody-drug conjugate (ADC) binding CD33, a protein on myeloid cells. The IND supports the initiation of a Phase 1 clinical trial, BLM11D1-HM-101, to evaluate the safety, tolerability, pharmacokinetics, […]

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Torrid Holdings Inc. ("Torrid Holdings Inc.") (NYSE:CURV) concerning possible violations of federal securities laws. On October 7, 2024, Torrid announced the termination of "Ms. Elizabeth Muñoz-Guzman, the [Company’s] Executive Vice President and Chief

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nomura Holdings, Inc. ("Nomura Holdings, Inc.") (NYSE:NMR) concerning possible violations of federal securities laws. Media outlets reported on September 30, 2024, that Nomura was excluded as lead manager for several yen bond deals

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. Humana is the subject of a Bloomberg article published on October 2, 2024, titled: "Humana Plunges as Insurer Falters on Medicare

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere Therapeutics, Inc.") (NASDAQ:TVTX) concerning possible violations of federal securities laws. Travere issued a press release on September 26, 2024, "announc[ing] a voluntary pause of enrollment in the Phase 3

Integration Between GoodData’s Data Application Platform and Witboost’s Platform to Automate Lifecycle Management, Deployment and Change Management SAN FRANCISCO, CA / ACCESSWIRE / October 14, 2024 / GoodData, a leading data analytics and business intelligence (BI) platform, and Witboost, a pioneering platform that streamlines data management, processes, and operations, today announced a strategic partnership to

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Beyond, Inc. ("Beyond, Inc.") (NYSE:BYON) concerning possible violations of federal securities laws. After the market closed on May 6, 2024, Beyond announced the company’s first quarter 2024 financial results and revealed first quarter

Melbourne, Florida, Oct. 14, 2024 (GLOBE NEWSWIRE) — Orion180, a leader in innovative insurance solutions today announced a multi-year partnership with the MoneyGram Haas F1 Team. The insurance trailblazer and America’s Formula 1 team will commence their multi-year partnership from the team’s home race, the United States Grand Prix, held at the Circuit of The

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Endava plc (NYSE:DAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/endava-lawsuit-submission-form?prid=108258&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=108257&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)